OCT 2014 ARTICLE LIST >>
PharmaTutor (October- 2014)
ISSN: 2347 - 7881
(Volume 2, Issue 10)
Received On: 05/08/2014; Accepted On: 07/08/2014; Published On: 01/10/2014
AUTHORS: Shoumik Roy*, Samil D. Desai, Bhavna A. Patel, Shraddha J. Parmar
Post Graduation Department of Pharmaceutical Sciences,
Sardar Patel University, Vallabh Vidyanagar, Gujarat, India.
roy.shoumik@gmail.com
ABSTRACT:
The main thrust of the paper was to develop and validate a simple, precise high performance thin-layer chromatographic (HPTLC) method for estimation of tapentadol hydrochloride in tablet dosage form. Chromatography was performed on silica gel 60 F254 plates with Chloroform: Acetone: Ammonia (2.5: 2.4: 0.1 v/v/v) as mobile phase. This mobile phase system gave a good resolution for tapentadol hydrochloride (Rf value of 0.49 ± 0.02). Detection and quantification were carried out at 272 nm. The linear regression data for the calibration plot showed a good relationship with r=0.999. The limits of detection and quantification were 62.68 and 189.94ng/spot for tapentadol hydrochloride. The amounts of the drugs in the marketed formulation were 99.98%.
How to cite this article: S Roy, SD Desai, BA Patel, SJ Parmar; Development and Validation of HPTLC Method for Estimation of Tapentadol Hydrochloride; PharmaTutor; 2014; 2(10); 136-141
[ABSTRACT WITH CITATION] [VIEW AS HTML]
REFERENCES:
1. Kneip C, R. Terlinden R, Beier H and Chen G. Investigations Into the Drug-Drug Interaction Potential of Tapentadol in Human Liver Microsomes and Fresh Human Hepatocytes. Drug Metabolism Letters, 2008; 2:67-75.
2. Tzschentke T, Christoph T, Babette K, Schiene K, Hennies H, W Englberger W, Haurand H. (–)-(1R,2R)-3-(3-Dimethylamino-1-ethyl-2-methyl-propyl)-phenol Hydrochloride (Tapentadol HCl): A Novel -Opioid Receptor Agonist/Norepinephrine Reuptake inhibitor with broad spectrum analgesic properties. The journal of pharmacology and experimental therapeutics, 2007; 32: 265-276.
3. Indian Pharmacopoeia. 6th ed. Ghaziabad: The Indian Pharmacopoeia Commission 2010.Volume- II, III, 1318-21, 1859-61.
4. United State Pharmacopoeia, 34th edition NF 29, Rockville: published by United State Pharmacopoeial Convention; 2011. Volume-II, III, 2784, 2786,1720, 1723.
5. Shaik A, Ramani DN, Agarwal NK. Method development and validation of Tapentadol Hydrochloride by RP-HPLC in Pure and Tablet Dosage Form. J Chem Pharma Sciences,2012; 5(4):178-80.
6. Ramanaiah G, Ramachandran D, Srinivas G, Jayapal G, Rao P, Srilakshmi V. Development and Validation of Stability Indicating RP-LC Method for Simultaneous Estimation of Tapentadol and Paracetamol in Bulk and its Pharmaceutical Formulations. Drug Inv Today, 2012:4(7):391-96.
7. Kanzariya RP, Patel TP, Kapuriya KG, Faldu SD. Method development and validation of Tapentadol hydrochloride by RP-HPLC method. Inventi Rapid:Pharm.Ana&Qual.Assur. 2012.
8. Babu BS, Pavan KK, Nataraj K, Ramakrishna K. Development and validation of UV-Visible spectrophotometric method for the determination of Tapentadol hydrochloride from tablet dosage form. Der Pharmacia Lettre, 2013; 5(2):377-382.
.png)
